Dhanji Rajani | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Dhanji Rajani | Immunology and Microbiology | Best Researcher Award

Microbiologist at Microcare laboratory and Tuberculosis research centre, India

Dr. Dhanji Popatbhai Rajani is a distinguished microbiologist with nearly two decades of experience in medical microbiology and diagnostics. He has made significant contributions to tuberculosis (TB) research, including evaluating innovative PCR tests for MDR TB and developing non-invasive, low-cost rapid diagnostics under prestigious government-funded projects like IMPRINT. With over 106 research publications and 24 patents, his work spans green synthesis, drug discovery, and sustainable methodologies. Dr. Rajani has received accolades such as the Best Performance Award for TB diagnosis from Surat Municipal Corporation in 2015 and 2016, highlighting his impact on public health. Currently leading diagnostics at Microcare Lab & TRC, he combines clinical expertise with research innovation. His leadership roles and commitment to advancing microbiology through cutting-edge research, sustainable practices, and impactful diagnostics establish him as a leading figure in his field, making him an exceptional candidate for recognition like the Best Researcher Award.

Professional ProfileΒ 

Education

Dr. Dhanji Popatbhai Rajani has a solid academic foundation in microbiology and medical diagnostics. He earned his Bachelor of Science (B.Sc) in Microbiology from the Sir P. P. Institute of Science in 2000, followed by a Postgraduate Diploma in Medical Laboratory Technology (PGDMLT) from K. K. Jani Paramedical Institute in 2001, which honed his technical expertise in laboratory sciences. Dr. Rajani further advanced his academic qualifications with a Master of Science (M.Sc) in Medical Microbiology from the Aditya Vikram Birla Post Graduate Institute in 2003, focusing on clinical and diagnostic microbiology. His academic journey culminated in a Ph.D. in Medical Microbiology from Bhavnagar University in 2012, where he specialized in advanced research methodologies and innovative diagnostics. This comprehensive education has laid the groundwork for his impactful career in microbiology, driving significant advancements in diagnostic research, particularly in tuberculosis and sustainable medical innovations.

Professional Experience

Dr. Dhanji Popatbhai Rajani has an extensive professional career in microbiology, marked by leadership roles and impactful contributions to clinical diagnostics. Since 2004, he has served as a Microbiologist at Microcare Lab & TRC, where he has led diagnostic and research initiatives, particularly in tuberculosis (TB) and other infectious diseases. From 2009 to 2013, he was the Chief Microbiologist at Smt. R. B. Shah Mahavir Hospital, where he spearheaded clinical diagnostic services and strengthened laboratory operations. With nearly two decades of experience, Dr. Rajani has established himself as a leader in medical microbiology, combining hands-on diagnostic expertise with cutting-edge research. His work has not only advanced TB diagnostics but also contributed to sustainable and innovative practices in microbiology. Dr. Rajani’s professional journey reflects a blend of clinical excellence, research innovation, and leadership, making him a pivotal figure in his field.

Research Interest

Dr. Dhanji Popatbhai Rajani’s research interests lie at the intersection of medical microbiology, innovative diagnostics, and sustainable scientific methodologies. He is deeply committed to advancing tuberculosis (TB) diagnostics, focusing on developing non-invasive, cost-effective, and rapid diagnostic tools that address global health challenges. His work also includes exploring green synthesis methods, such as using natural catalysts, to create sustainable and environmentally friendly processes in drug development. Dr. Rajani’s research encompasses the design and biological evaluation of novel compounds with antifungal, antimalarial, and antitubercular properties, integrating advanced techniques like molecular docking, ADME-Tox analysis, and pharmacophore modeling. With a keen interest in sustainable innovations, he has also contributed to the synthesis of bioactive compounds using eco-friendly methods. Dr. Rajani’s multidisciplinary approach reflects his commitment to improving public health through groundbreaking research and sustainable solutions, positioning him as a leader in medical microbiology and diagnostics.

Award and Honor

Dr. Dhanji Popatbhai Rajani has been recognized for his outstanding contributions to medical microbiology and diagnostics through several prestigious awards and honors. He received the Best Performance Award for TB diagnosis from the Surat Municipal Corporation in both 2015 and 2016, acknowledging his excellence in advancing tuberculosis diagnostics and public health impact. These accolades highlight his dedication to combating TB through innovative diagnostic solutions and his commitment to improving healthcare outcomes. Dr. Rajani’s work has garnered widespread appreciation for its relevance and effectiveness in addressing critical challenges in infectious disease management. These honors underscore his ability to translate research into practical applications, benefiting communities and setting new standards in diagnostic microbiology. With his achievements and consistent recognition, Dr. Rajani has established himself as a leading figure in his field, making significant strides in medical innovation and public health.

Conclusion

Dr. Dhanji Popatbhai Rajani is a strong candidate for the Best Researcher Award due to his extensive contributions to medical microbiology, particularly in TB diagnostics and drug synthesis. His robust portfolio of research papers, patents, and awards, combined with leadership in impactful projects, underscores his eligibility. Strengthening international collaboration and diversifying research impact would further elevate his profile for future recognition.

Publications Top Noted

  • Title: Synthesis of benzimidazolyl-1, 3, 4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl) acetamides as antibacterial, antifungal and antituberculosis agents
    Authors: RV Patel, PK Patel, P Kumari, DP Rajani, KH Chikhalia
    Year: 2012
    Citation: 191
  • Title: Synthesis and identification of Ξ²-aryloxyquinolines and their pyrano [3, 2-c] chromene derivatives as a new class of antimicrobial and antituberculosis agents
    Authors: DC Mungra, MP Patel, DP Rajani, RG Patel
    Year: 2011
    Citation: 161
  • Title: A strategic approach to the synthesis of functionalized spirooxindole pyrrolidine derivatives: in vitro antibacterial, antifungal, antimalarial and antitubercular studies
    Authors: S Haddad, S Boudriga, TN Akhaja, JP Raval, F Porzio, A Soldera, M Askri, DP Rajani
    Year: 2015
    Citation: 112
  • Title: Synthesis and studies of novel 2-(4-cyano-3-trifluoromethylphenyl amino)-4-(quinoline-4-yloxy)-6-(piperazinyl/piperidinyl)-s-triazines as potential antimicrobial agents
    Authors: RV Patel, P Kumari, DP Rajani, KH Chikhalia
    Year: 2011
    Citation: 109
  • Title: Synthesis of coumarin-based 1,3,4-oxadiazol-2ylthio-N-phenyl/benzothiazolyl acetamides as antimicrobial and antituberculosis agents
    Authors: RV Patel, P Kumari, DP Rajani, KH Chikhalia
    Year: 2013
    Citation: 105
  • Title: Antimicrobial, Anti-TB, Anticancer and Anti-HIV Evaluation of New s-Triazine-Based Heterocycles
    Authors: RV Patel, P Kumari, DP Rajani, C Pannecouque, E De Clercq, KH Chikhalia
    Year: 2012
    Citation: 79
  • Title: New 2-benzylsulfanyl-nicotinic acid based 1, 3, 4-oxadiazoles: Their synthesis and biological evaluation
    Authors: NB Patel, AC Purohit, DP Rajani, R Moo-Puc, G Rivera
    Year: 2013
    Citation: 76
  • Title: Hydroxyl alkyl ammonium ionic liquid assisted green and one-pot regioselective access to functionalized pyrazolodihydropyridine core and their pharmacological evaluation
    Authors: DM Patel, MG Sharma, RM Vala, I Lagunes, A Puerta, JM PadrΓ³n, DP Rajani
    Year: 2019
    Citation: 72
  • Title: Synthesis, characterization and pharmacological activities of 2-[4-cyano-(3-trifluoromethyl) phenyl amino)]-4-(4-quinoline/coumarin-4-yloxy)-6-(fluoropiperazinyl)-s-triazines
    Authors: RV Patel, P Kumari, DP Rajani, KH Chikhalia
    Year: 2011
    Citation: 68
  • Title: A Practical Green Visit to the Functionalized [1,2,4]Triazolo[5,1‐b]quinazolin‐8(4H)one Scaffolds Using the Group‐Assisted Purification (GAP) Chemistry and Their Biological Evaluation
    Authors: DM Patel, RM Vala, MG Sharma, DP Rajani, HM Patel
    Year: 2019
    Citation: 65
  • Title: Synthesis and evaluation of new chalcones, derived pyrazoline and cyclohexenone derivatives as potent antimicrobial, antitubercular and antileishmanial agents
    Authors: V Monga, K Goyal, M Steindel, M Malhotra, DP Rajani, SD Rajani
    Year: 2014
    Citation: 64
  • Title: Green approach for synthesis of bioactive Hantzsch 1, 4-dihydropyridine derivatives based on thiophene moiety via multicomponent reaction
    Authors: MG Sharma, DP Rajani, HM Patel
    Year: 2017
    Citation: 57

 

Ani Ioana Cotar | Immunology | Best Researcher Award

Posted on by ScienceFather

Ani Ioana Cotar | Immunology | Best Researcher Award

PhD, senior researcher at Cantacuzino Research Institute, Romania.

Dr. Ani Ioana Cotar is a distinguished research scientist and head of the National Center for Expertise and Intervention in Public Health for Biological, Chemical, Radiological, and Nuclear Agents at the “Cantacuzino” National Medico-Military Institute in Bucharest, Romania. Her career spans over 20 years, specializing in virology and vector-borne infections, including high-impact diseases such as West Nile, Zika, and Chikungunya viruses. Her expertise in molecular diagnostics and pathogen characterization has positioned her at the forefront of infectious disease research, with extensive experience in immunology and molecular biology techniques. Dr. Cotar’s significant role in global health initiatives is underscored by her work with the EVDLabNet and WHO in external quality assurance (EQA) schemes. Her commitment to advancing public health and her innovative research approaches make her a prominent figure in the field, with her contributions directly impacting diagnostic accuracy and understanding of viral pathogen epidemiology.

Professional Profile

Education

Dr. Cotar’s educational background includes a Ph.D. in Biology from the Faculty of Biology, University of Bucharest, completed in 2009. She holds an MSc in Genetics from the same institution and a BSc in Biology. Additionally, she completed two postdoctoral fellowships; one at the University of Bucharest, where she deepened her understanding of molecular biology, and the other under the European Program for Public Health Microbiology (EUPHEM) in Stockholm. This extensive education laid the groundwork for her career in vector-borne infections and public health. Her advanced studies, particularly in molecular epidemiology, prepared her for her pioneering role in pathogen identification and control. Dr. Cotar’s academic accomplishments highlight her commitment to integrating science with public health practices to improve diagnostic protocols and preventive strategies against infectious diseases.

Professional Experience

Dr. Cotar began her career at the “Cantacuzino” Institute in 2001 as a biologist and progressed to roles of increasing responsibility, becoming a Research Scientist I by 2022 and Head of the National Center in 2023. Her experience includes leading projects on the molecular diagnostics of high-risk vector-borne pathogens and implementing quality assurance testing for the WHO. Her work includes crucial contributions to SARS-CoV-2 diagnostics during the pandemic and coordinating whole-genome sequencing for bacterial pathogens. She has developed protocols for DNA/RNA extraction, PCR, and real-time PCR, bringing rigorous scientific standards to her laboratory’s practices. Her leadership and technical expertise have contributed to significant advancements in Romania’s capacity to detect, monitor, and respond to infectious disease threats, particularly in vector-borne pathogens affecting both national and global health landscapes.

Research Interest

Dr. Cotar’s research interests lie in the molecular epidemiology and diagnostics of viral and bacterial vector-borne pathogens. Her work focuses on identifying and characterizing infectious agents such as West Nile, Zika, and Chikungunya viruses, as well as bacterial pathogens like Rickettsia and Borrelia. She is committed to improving diagnostic capabilities through molecular biology techniques, including PCR, DNA sequencing, and bioinformatics. Dr. Cotar’s research extends to quality assurance, participating in global quality initiatives that enhance laboratory accuracy for pathogen detection. Her expertise in molecular typing and genome sequencing reflects her focus on understanding pathogen transmission, evolution, and resistance, critical for developing effective public health interventions.

Award and Honor

Dr. Cotar has been recognized for her contributions to public health and infectious disease research. Her work on the frontlines of SARS-CoV-2 diagnostics and her efforts to establish protocols for emerging viral and bacterial pathogens have earned her respect within the scientific community. She has received accolades for her role in quality assurance initiatives with the WHO and her contributions to the EVDLabNet. These recognitions underscore her commitment to improving diagnostic accuracy and public health response capabilities, and her dedication has positioned her as an authority in virology and infectious disease research in Romania and beyond.

Conclusion

Dr. Cotar’s deep specialization in vector-borne infectious diseases, coupled with her proven track record in molecular diagnostics and quality assurance, establishes her as a leading candidate for the Best Researcher Award. Her consistent contributions are essential to advancing both national and global health research on infectious diseases.

Publications top noted

Title: Increasing the Awareness of Under-Diagnosed Tropical Cases of Dengue in Romania
Authors: Cismaru, I.M., Radu, M.A., Cotar, A.I., Ghemulet, I., Gheorghita, V.
Year: 2023
Citation: Tropical Medicine and Infectious Disease, 2023, 8(10), 469.

Title: First Detection and Molecular Characterization of Usutu Virus in Culex pipiens Mosquitoes Collected in Romania
Authors: Prioteasa, F.L., Dinu, S., Tiron, G.V., Ceianu, C.S., Cotar, A.I.
Year: 2023
Citation: Microorganisms, 2023, 11(3), 684.

Title: Distribution of Insecticide Resistance Genetic Markers in the West Nile Virus Vector Culex pipiens from South-Eastern Romania
Authors: Stancu, I.G., Prioteasa, F.L., Tiron, G.V., Ceianu, C.S., Csutak, O.
Year: 2022
Citation: Insects, 2022, 13(11), 1062.

Title: Original Contributions to the Chemical Composition, Microbicidal, Virulence-Arresting, and Antibiotic-Enhancing Activity of Essential Oils from Four Coniferous Species
Authors: Visan, D.-C., Oprea, E., Radulescu, V., Chifiriuc, M.C., Marinas, I.C.
Year: 2021
Citation: Pharmaceuticals, 2021, 14(11), 1159.

Title: Characterization and Host-Feeding Patterns of Culex pipiens s.l. Taxa in a West Nile Virus-Endemic Area in Southeastern Romania
Authors: Tiron, G.V., Stancu, I.G., Dinu, S., Ceianu, C.S., Cotar, A.I.
Year: 2021
Citation: Vector-Borne and Zoonotic Diseases, 2021, 21(9), pp. 713–719.

Title: Emergence of Toscana Virus, Romania, 2017-2018
Authors: Popescu, C.P., Cotar, A.I., Dinu, S., Ceianu, C.S., Florescu, S.A.
Year: 2021
Citation: Emerging Infectious Diseases, 2021, 27(5), pp. 1482–1485.

Title: Increased Risk of Chikungunya Infection in Travelers to Thailand During Ongoing Outbreak in Tourist Areas: Cases Imported to Europe and the Middle East, Early 2019
Authors: Javelle, E., Florescu, S.-A., Asgeirsson, H., Hamer, D.H., Gautret, P.
Year: 2019
Citation: Eurosurveillance, 2019, 24(10), 1900146.

Title: West Nile Virus Lineage 2 in Romania, 2015-2016: Co-Circulation and Strain Replacement
Authors: Cotar, A.I., Fǎlcuţǎ, E., Dinu, S., Ceianu, C.S., Prioteasa, F.L.
Year: 2018
Citation: Parasites and Vectors, 2018, 11(1), 562.

Title: Re-Emergence of Severe West Nile Virus Neuroinvasive Disease in Humans in Romania, 2012 to 2017 – Implications for Travel Medicine
Authors: Popescu, C.P., Florescu, S.A., Cotar, A.I., Ceausu, E., Ruta, S.M.
Year: 2018
Citation: Travel Medicine and Infectious Disease, 2018, 22, pp. 30–35.

Title: Lack of Zika Virus Antibody Response in Confirmed Patients in Non-Endemic Countries
Authors: Lustig, Y., Cotar, A.I., Ceianu, C.S., Aarons, E., Reusken, C.
Year: 2018
Citation: Journal of Clinical Virology, 2018, 99-100, pp. 31–34.

Abdolghaffar Ownagh | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Abdolghaffar Ownagh | Immunology and Microbiology | Best Researcher Award

Professor in microbiology Department at Urmia University, Iran

Prof. Dr. Abdolghaffar Ownagh is a distinguished academic and researcher in the field of veterinary microbiology, currently serving as a Professor in the Department of Microbiology at Urmia University, Iran. He holds a DVM and a DVSc in Microbiology, with extensive teaching experience spanning over three decades, covering courses in veterinary and medical mycology, bacteriology, and general microbiology. Dr. Ownagh has made significant contributions to the field, authoring numerous publications focused on microbial pathogenesis and the use of natural products in veterinary medicine. His research includes molecular detection of pathogens and antifungal treatments, showcasing a commitment to advancing veterinary science. Additionally, he has supervised the theses of multiple PhD and MSc students, fostering the development of future researchers. Dr. Ownagh’s expertise and dedication to teaching and research position him as a leading figure in veterinary microbiology, making substantial contributions to both academia and the scientific community.

Professional Profile

Education

Prof. Dr. Abdolghaffar Ownagh has a robust educational background in veterinary medicine and microbiology. He obtained his Doctor of Veterinary Medicine (DVM) degree from Urmia University, Iran, from 1987 to 1992, where he conducted his thesis on colibacillar diarrhea in calves. He furthered his studies by earning a Doctorate of Veterinary Science (DVSc) in Microbiology from the same institution between 2001 and 2007, focusing on the effects of various essential oils on fungi associated with Artemia urmiana. This comprehensive education has provided Dr. Ownagh with a solid foundation in veterinary science and microbiological research. His academic journey reflects a deep commitment to the field, equipping him with the necessary expertise to excel in teaching and research. Dr. Ownagh’s educational credentials have significantly contributed to his role as a leading figure in veterinary microbiology at Urmia University, where he continues to inspire and mentor future professionals in the field.

Professional Experience

Prof. Dr. Abdolghaffar Ownagh has amassed extensive professional experience in academia and research over his three-decade career. He is currently a Professor in the Department of Microbiology at Urmia University, Iran, where he has been instrumental in teaching a wide range of subjects, including veterinary and medical mycology, bacteriology, and general microbiology for DVM, MSc, and PhD students since 1993. In addition to his teaching responsibilities, Dr. Ownagh has supervised over 50 graduate and postgraduate theses, demonstrating his commitment to nurturing the next generation of researchers in veterinary sciences. His research efforts focus on microbial pathogenesis, antifungal treatments, and the application of natural products in veterinary medicine. Dr. Ownagh’s leadership in academia and his dedication to advancing knowledge in veterinary microbiology have established him as a prominent figure in his field, contributing significantly to both education and research initiatives at Urmia University.

Research Interest

Prof. Dr. Abdolghaffar Ownagh’s research interests encompass a broad spectrum within veterinary microbiology, with a strong emphasis on microbial pathogenesis and the exploration of natural products for therapeutic applications. His work primarily investigates the molecular detection and phylogenetic analysis of various pathogens affecting livestock, particularly focusing on zoonotic diseases and their impact on animal and human health. Dr. Ownagh has conducted significant research on the antifungal properties of essential oils and natural extracts, such as propolis, evaluating their effectiveness against fungal infections in veterinary settings. His studies also include the characterization of antibiotic resistance in bacterial pathogens and the development of innovative treatments for infections in animals. By integrating microbiological research with practical veterinary applications, Dr. Ownagh aims to enhance disease management strategies in livestock and contribute to the overall improvement of animal health and welfare. His commitment to advancing knowledge in this field positions him as a key contributor to veterinary science.

Award and honor

Prof. Dr. Abdolghaffar Ownagh has received several awards and honors throughout his distinguished academic and research career, recognizing his contributions to veterinary microbiology and education. His commitment to excellence in teaching has been acknowledged by the faculty at Urmia University, where he has played a pivotal role in shaping the curriculum and mentoring students at various academic levels. Dr. Ownagh’s research contributions have also garnered recognition within the scientific community, particularly for his innovative studies on microbial pathogenesis and the application of natural products in veterinary medicine. He has published extensively in reputable journals, earning accolades for his significant findings in the field. Additionally, Dr. Ownagh’s efforts to supervise and guide numerous graduate students have contributed to the development of future researchers, further solidifying his reputation as a dedicated educator and leader. These awards and honors reflect his unwavering dedication to advancing knowledge and improving practices within veterinary sciences.

Conclusion

Abdolghaffar Ownagh demonstrates strong qualifications for the Best Researcher Award, reflecting his extensive academic and research background, a significant body of work in microbiology, and a commitment to teaching and mentoring. By focusing on interdisciplinary collaborations, increasing his publication footprint, and pursuing more funding opportunities, he can further elevate his impact in the field of veterinary microbiology. His contributions are invaluable, making him a strong candidate for recognition in this prestigious award.

Publications top noted

  1. 🦠 Molecular survey and phylogenetic analysis of Bartonella henselae and Bartonella clarridgeiae in dogs from northwest Iran
    Rajabi, S.A., Ownagh, A., Hadian, M.
    Journal of Zoonotic Diseases, 2024, 8(4), pp. 610–620
  2. πŸ”¬ Molecular and genotyping techniques in diagnosis of Coxiella burnetii: An overview
    Khademi, P., Tukmechi, A., Sgroi, G., Khalili, M., Mardani, K.
    Infection, Genetics and Evolution, 2024, 123, 105655
  3. 🐾 Molecular detection and phylogenetic analysis of Borrelia spp. in blood samples of cats and dogs by the nested-PCR method in West Azerbaijan Province, Iran
    Ownagh, A., Rajabi, S.A., Enferadi, A., Hadian, M.
    Brazilian Journal of Microbiology, 2024, 55(3), pp. 2915–2922
  4. πŸ’§ Identification of a lytic bacteriophage against clinical isolates of Salmonella typhimurium in turkey poults
    Amini, M., Ownagh, A., Tukmechi, A., Allymehr, M.
    Veterinary Research Forum, 2024, 15(6), pp. 309–316
  5. 🐦 Molecular and histopathological survey of Francisella spp., Borrelia spp. and Leptospira spp. in ornamental birds of four provinces of Iran
    Enferadi, A., Ownagh, A., Nofouzi, K., Khordadmehr, M.
    Gene Reports, 2024, 35, 101921
  6. 🌱 Application of Propolis Ethanol Extract and Propolis Nanoemulsion in Treatment of Cutaneous Infection in Rabbit
    Archin, T., Ownagh, A., Tehrani, A.A., Keshipour, S.
    Iranian Journal of Veterinary Surgery, 2024, 19(1), pp. 8–18
  7. πŸ„ Therapeutic effects of propolis ethanolic extract on infectious bovine keratoconjunctivitis in cows
    Bahmani, T., Najarnezhad, V., Ownagh, A.
    Journal of Advanced Veterinary Research, 2024, 14(4), pp. 586–590
  8. 🦎 First molecular detection of Francisella tularensis in turtle (Testudo graeca) and ticks (Hyalomma aegyptium) in Northwest of Iran
    Tukmechi, A., Ownagh, A., Enferadi, A., Khademi, P.
    International Journal for Parasitology: Parasites and Wildlife, 2024, 23, 100892
  9. πŸ‘ Molecular detection and phylogenetic analysis of Borrelia spp. from sheep and goats blood samples in West Azerbaijan province, Iran
    Enferadi, A., Ownagh, A., Tavassoli, M.
    Veterinary Research Forum, 2024, 15(2), pp. 89–95
  10. 🐱 Genomic detection and phylogenetic analysis of Bartonella quintana in pet cats from Urmia City, Northwest Iran
    Rajabi, S.A., Ownagh, A., Hadian, M.
    Comparative Immunology, Microbiology and Infectious Diseases, 2024, 105, 102125

Shanaz sharaf | Immunology and histopathology | Best Researcher Award

Posted on by ScienceFather

Mrs. Shanaz sharaf | Immunology and histopathology | Best Researcher Award

PhD Scholar of Regional Cancer Centre, India

Mrs. Shanaz Sharaf is a dedicated researcher with 7 years of experience in biotechnology, biomedical sciences, cell and molecular biology, and clinical research. πŸŽ“ Her work primarily focuses on understanding prognostic tumor markers in Triple Negative Breast Cancer (TNBC), exploring molecular and cell signaling aspects in tumorigenesis, and developing innovative technologies for cancer detection. 🧬 Passionate about advancing cancer research, Mrs. Sharaf is committed to creating novel multiplex technologies for tumor tissue imaging. She aims to leverage her skills and knowledge in a collaborative environment to contribute to cutting-edge scientific advancements and gain exposure to emerging technologies. 🌟

Professional profile

EducationπŸ“š

Mrs. Shanaz Sharaf holds a Doctor of Philosophy (Ph.D.) in Biotechnology from Manipal Academy of Higher Education, India, where she conducted research on prognostic markers and multiplex platforms for breast cancer classification. πŸ“š Her academic journey includes a Master of Science in Biotechnology from the University of Kerala, graduating with first-class honors and a distinction of 75.05%. πŸŽ“ Prior to that, she earned a Bachelor of Science in Botany and Biotechnology from the University of Kerala, also with first-class honors and a notable 74.05%. 🌟 Her educational background equips her with a strong foundation in biotechnological and biomedical sciences, essential for her research endeavors.

Professional ExperienceπŸ›οΈ

Mrs. Shanaz Sharaf brings a wealth of experience to her field, having served as a PhD Scholar at the Regional Cancer Centre, Thiruvananthapuram, Kerala, India, from 2019 to 2024. πŸŽ“ Her research focused on identifying prognostic markers and developing multiplex platforms for breast cancer classification under the guidance of Dr. K Sujathan. 🧬 Prior to her PhD, she worked as a Junior Research Fellow on translational research in Triple Negative Breast Cancer (2017-2019) and investigated maternal sleep deprivation effects on offspring cognition (2014-2015) at SCTIMST, Thiruvananthapuram. πŸ”¬ Her extensive research background showcases her expertise in molecular and cell biology, particularly in cancer research and innovative diagnostic techniques. πŸ§ͺ

Research Interest🌐

Mrs. Shanaz Sharaf’s research interests lie in the intersection of biotechnology and cancer research. πŸ”¬ Her primary focus is on understanding the role of prognostic tumor markers in Triple Negative Breast Cancer (TNBC), aiming to enhance disease outcome predictions and improve detection methods. 🧬 She explores various molecular and cell signaling pathways involved in tumorigenesis and is passionate about developing novel multiplex technologies for tumor tissue imaging. πŸ§ͺ Her work seeks to innovate cancer detection and treatment, leveraging cutting-edge techniques to advance the field of oncology. 🌟

Awards and HonorsπŸ†

Mrs. Shanaz Sharaf has received notable recognition for her contributions to cancer research and biotechnology. πŸ… Her commitment to advancing the field has been acknowledged through various awards and honors. πŸŽ–οΈ These accolades highlight her innovative work and dedication, reflecting her impact on the scientific community and her role in pioneering new approaches to cancer detection and treatment. 🌟 Her achievements underscore her excellence and commitment to improving health outcomes through research and innovation. 🌺

AchievementsπŸ…
  • πŸŽ“ Doctoral Research: Completed a Ph.D. in Biotechnology at Manipal Academy of Higher Education, focusing on identifying prognostic markers and developing multiplex platforms for breast cancer classification.
  • 🧬 Research Contributions: Significant work in Triple Negative Breast Cancer, including translational research and novel strategies in cancer detection.
  • πŸ”¬ Conference Organization: Actively involved in organizing major conferences like the Indo-Swedish Conference on Analytical Cell Biology and Machine Learning in Cancer Research (2019) and the National Conference on ETHB (2023).
  • πŸ“š Research Experience: Junior Research Fellow (JRF) with projects on maternal sleep deprivation effects and translational research in breast cancer.
  • πŸ† Professional Recognition: Contributed to significant research advancements and gained recognition within the scientific community for her innovative approaches and findings.
  • πŸ’‘ Innovative Technologies: Development of innovative multiplex technologies for tumor tissue imaging, enhancing cancer research methodologies.
ProjectsπŸ› οΈ
  • πŸ” Prognostic Markers in Breast Cancer: Identified a panel of prognostic markers and developed a multiplex platform for histoclinical classification of breast cancer during her Ph.D. research at the Regional Cancer Centre.
  • 🧬 Triple Negative Breast Cancer: Conducted translational research focusing on the role of various prognostic tumor markers in Triple Negative Breast Cancer.
  • πŸ§ͺ Maternal Sleep Deprivation Study: Investigated the effects of maternal sleep deprivation on cognition in offspring using an animal model during her tenure as a Junior Research Fellow.
  • 🧩 Tumor Tissue Imaging: Worked on developing innovative multiplex technologies for enhanced imaging of tumor tissues.
  • πŸ—‚οΈ Conference Organization: Played a key role in organizing major conferences, including the Indo-Swedish Conference on Analytical Cell Biology and Machine Learning in Cancer Research and the National Conference on ETHB.
Publications top notedπŸ“œ
  • πŸ“„ “Subcellular expression of MTA1, HIF1A, and p53 in primary tumor predicts aggressive triple negative breast cancers: a meta-analysis based study”
    • Authors: Sharaf, S.S., Jaganath Krishna, K.M., Lekshmi, A., Sujathan
    • Journal: Journal of Molecular Histology
    • Year: 2024
    • Volume: 55
    • Issue: 3
    • Pages: 303–315
    • Citations: 0
  • πŸ“„ “A multiplex immunoprofiling approach for detecting the co-localization of breast cancer biomarkers using a combination of Alexafluor – Quantum dot conjugates and a panel of chromogenic dyes”
    • Authors: Sharaf, S.S., Lekshmi, A., S, A., Santhosh Kumar, T.R., K, S.
    • Journal: Pathology Research and Practice
    • Year: 2024
    • Volume: 253
    • Article: 155033
    • Citations: 1